-transparent.png){kind=logo}
We describe a synergistic effect of combinations of foscarnet and 3'-azido-3'-deoxythymidine against human immunodeficiency virus type 1 multiplication in cell culture, an additive effect of foscarnet and 3'-azido-3'-deoxythymidine triphosphate against human immunodeficiency virus type 1 reverse transcriptase, and a low toxicity in cell culture of combinations of the two drugs.
Related Publications
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
October 1990,
AIDS research and human retroviruses,
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
May 1989,
Antimicrobial agents and chemotherapy,
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
June 1989,
Antimicrobial agents and chemotherapy,
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
June 1990,
Antimicrobial agents and chemotherapy,
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
December 1988,
Antimicrobial agents and chemotherapy,
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
October 1990,
Biochemical and biophysical research communications,
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
May 1996,
Antimicrobial agents and chemotherapy,
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
January 1989,
Antimicrobial agents and chemotherapy,
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
October 1991,
Antimicrobial agents and chemotherapy,
R Koshida, and
L Vrang, and
G Gilljam, and
J Harmenberg, and
B Oberg, and
B Wahren
November 1988,
Antimicrobial agents and chemotherapy,
